Biosimilar Newsletter Archive

41. 08.16.18 -- What To Watch In The Biosimilar Regulatory Space
    8/16/2018

    08/16/18 Biosimilar Development Newsletter

42. 08.09.18 -- EU Turns Focus To Biosimilar Sustainability Questions
    8/9/2018

    08/09/18 Biosimilar Development Newsletter

43. 08.07.18 -- Speed To Market Strategies For Biosimilar Manufacturers
    8/7/2018
    08/07/18 Biosimilar Development Newsletter
44. 08.02.18 -- Samsung Bioepis: From Biosimilars To Novel Biologics
    8/2/2018

    08/02/18 Biosimilar Development Newsletter

45. 07.26.18 -- 3 Biosimilar Market Access Experiences
    7/26/2018

    07/26/18 Biosimilar Development Newsletter

46. 07.19.18 -- 4 Conversations Integral To Biosimilar Partnerships
    7/19/2018

    07/19/18 Biosimilar Development Newsletter

47. 07.12.18 -- Lit Review Pushback Highlights Areas For Future Study
    7/12/2018

    07/12/18 Biosimilar Development Newsletter

48. 07.05.18 -- FDA's Latest Move Worthy Of Celebration
    7/5/2018

    07/05/18 Biosimilar Development Newsletter

49. 06.29.18 -- Downstream Virus Purification Platforms
    6/29/2018
    06/29/18 Biosimilar Development Newsletter
50. 06.27.18 -- Cell Therapy Solutions For Every Step
    6/27/2018
    06/27/18 Biosimilar Development Newsletter